Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-01, Stock:JNJ, The news for the past five days is as follows:
2019-06-24: NEWS1: 3 Top Healthcare Stocks to Buy Right Now.NEWS2: 3 Top Healthcare Stocks to Buy Right Now.NEWS3: LifeScan Global Corporation -- Moody's announces completion of a periodic review of ratings of LifeScan Global Corporation.NEWS4: Oklahoma judge approves Teva's $85 million opioid settlement.NEWS5: How Chinese Culture Could Affect the Future of 3M Stock.NEWS6: 3 Top Healthcare Stocks to Buy Right Now.NEWS7: How Chinese Culture Could Affect the Future of 3M Stock.NEWS8: Minerva Spikes Higher After Novel Insomnia Drug Aces Mid-Stage Trial.NEWS9: 3 Excellent Dividend Aristocrats You Can Buy Right Now.NEWS10: 3 Excellent Dividend Aristocrats You Can Buy Right Now.NEWS11: 3 Excellent Dividend Aristocrats You Can Buy Right Now.NEWS12: The rise of the anti-vaxxers is bad news for business.
2019-06-25: NEWS1: Axsome Initiates Phase III Study on Depression Candidate.NEWS2: Axsome Initiates Phase III Study on Depression Candidate.NEWS3: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS4: 3 Healthcare Stocks to Buy With the Market Near All-Time Highs.NEWS5: 3 Healthcare Stocks to Buy With the Market Near All-Time Highs.NEWS6: Axsome Initiates Phase III Study on Depression Candidate.NEWS7: Dow Movers: GS, JNJ.NEWS8: Dow Movers: GS, JNJ.NEWS9: What to Expect from Johnson & Johnson and Gilead Sciences’ EPS.NEWS10: Health Care Sector Update for 06/25/2019: AGN, GMDA, DERM, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 06/25/2019: AGN, GMDA, DERM, JNJ, PFE, ABT, MRK, AMGN.NEWS12: How Are Johnson & Johnson’s Revenues Trending in 2019?.NEWS13: Why J&J’s Fallen Stock Is Still Too Pricey.NEWS14: Why J&J's Stock May Plunge 10%.NEWS15: What Are Analysts Recommending for Johnson & Johnson and Gilead?.NEWS16: An Argus Research Portfolio for Sustainable Impact Stocks.
2019-06-26: NEWS1: Pacira Gets EMA Acceptance for Pain Management Drug Exparel.NEWS2: Will Democrats Slam Drug Prices? Health Care Stocks Dive Ahead Of Debate.NEWS3: Noteworthy Wednesday Option Activity: ISRG, JNJ, STX.NEWS4: Noteworthy Wednesday Option Activity: ISRG, JNJ, STX.NEWS5: Morphic Holding IPO: What You Need To Know.NEWS6: 3 Top-Performing Large-Cap Stocks.NEWS7: Dow Movers: MRK, INTC.NEWS8: Dow Movers: MRK, INTC.NEWS9: How JNJ and Gilead Are Working to Expand Their Portfolios.NEWS10: Here Are Johnson & Johnson’s Key Growth Drivers in Fiscal 2019.NEWS11: Israeli health tech startup DayTwo raises $31 million.NEWS12: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS13: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS14: 3 Biopharma Stocks to Buy for Income.NEWS15: 3 Biopharma Stocks to Buy for Income.
2019-06-27: NEWS1: Bayer Roundup Legal Adviser Known for Fighting, Not Settling.NEWS2: IWD, JNJ, WMT, MDT: Large Inflows Detected at ETF.NEWS3: IWD, JNJ, WMT, MDT: Large Inflows Detected at ETF.NEWS4: First Democratic Debate Eases Worry Over a Health-Insurance Overhaul.NEWS5: Lightning Strikes Boeing Once Too Often.
2019-06-28: NEWS1: Boston Scientific May Be Too Rich for Johnson & Johnson.NEWS2: J&J's Darzalex Gets FDA Nod for First-Line Multiple Myeloma.NEWS3: J&J's Darzalex Gets FDA Nod for First-Line Multiple Myeloma.NEWS4: Highly Rated Biotech Downgraded After Breaking Out And Running 39%.NEWS5: J&J's Darzalex Gets FDA Nod for First-Line Multiple Myeloma.NEWS6: Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger.NEWS7: Can Roche's #1 Therapeutic Area With $28 Billion In Revenue Grow Further?.NEWS8: Can Roche's #1 Therapeutic Area With $28 Billion In Revenue Grow Further?.NEWS9: Martin Gilbert branches out.

Answer: Rise